Picture of Athenex logo

ATNXQ — Athenex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Athenex Announces European Commission Approval Of Klisyri® (Tirbanibulin) For The Topical Treatment Of Actinic Keratosis

July 19 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX ANNOUNCES EUROPEAN COMMISSION APPROVAL OF KLISYRI®
(TIRBANIBULIN) FOR THE TOPICAL TREATMENT OF ACTINIC KERATOSIS

Source text for Eikon:  ID:nGNX60BBgh 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Athenex

See all news